Authors:
Tournigand, C
Louvet, C
Molitor, JL
Dehni, N
Lejeune, V
Sezeur, A
Pigne, A
Marpeau, L
Cady, J
de Gramont, A
Citation: C. Tournigand et al., Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma, GYNECOL ONC, 83(2), 2001, pp. 198-204
Authors:
Louvet, C
de Gramont, A
Tournigand, C
Artru, P
Maindrault-Goebel, F
Krulik, M
Citation: C. Louvet et al., Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma, CANCER, 91(11), 2001, pp. 2033-2038
Authors:
Louvet, C
Coudray, AM
Tournigand, C
Prevost, S
Raymond, E
de Gramont, A
Chazard, M
Gespach, C
Citation: C. Louvet et al., Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice, ANTI-CANC D, 11(7), 2000, pp. 579-582
Authors:
Mazars, A
Tournigand, C
Mollat, P
Prunier, C
Ferrand, N
Bourgeade, MF
Gespach, C
Atfi, A
Citation: A. Mazars et al., Differential roles of JNK and Smad2 signaling pathways in the inhibition of c-Myc-induced cell death by TGF-beta, ONCOGENE, 19(10), 2000, pp. 1277-1287
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles, V
Lotz, JP
Tournigand, C
Mabro, M
Molitor, JL
Artru, P
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer, ANN ONCOL, 11(11), 2000, pp. 1477-1483
Authors:
Andre, T
Louvet, C
Raymond, E
Tournigand, C
de Gramont, A
Citation: T. Andre et al., Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen, ANN ONCOL, 9(11), 1998, pp. 1251-1253